Issued Patents All Time
Showing 1–25 of 29 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12404523 | Adeno-associated virus delivery of CLN3 polynucleotide | Kathrin Christine Meyer, Kevin Foust | 2025-09-02 |
| 12357663 | Intrathecal delivery of recombinant adeno-associated virus encoding methyl-CpG binding protein 2 | Kevin Foust | 2025-07-15 |
| 12228571 | Cell-based assay for measuring drug product potency | Allan Arman KASPAR, Kevin Foust, Martin Fugére, Eunhye Park, Gretchen THOMSEN +1 more | 2025-02-18 |
| 12208144 | Intrathecal delivery of recombinant adeno-associated virus 9 | Arthur Burghes, Paul Porensky | 2025-01-28 |
| 12168777 | Means and method for producing and purifying viral vectors | James Michael HATFIELD, Joseph BALLEYDIER, Allan Arman KASPAR, Robert Emil Hodge | 2024-12-17 |
| 12077748 | Methods and materials for producing recombinant viruses in eukaryotic microalgae | — | 2024-09-03 |
| 11738094 | Intrathecal delivery of recombinant adeno-associated virus 9 | Arthur Burghes, Paul Porensky | 2023-08-29 |
| 11730829 | Intrathecal delivery of recombinant adeno-associated virus 9 | Arthur Burghes, Paul Porensky | 2023-08-22 |
| 11583564 | Intrathecal delivery of recombinant adeno-associated virus encoding Methyl-CpG binding protein 2 | Kevin Foust | 2023-02-21 |
| 11413357 | Intrathecal delivery of recombinant adeno-associated virus 9 | Arthur Burghes, Paul Porensky | 2022-08-16 |
| 11311634 | Intrathecal delivery of recombinant Adeno-associated virus 9 | Arthur Burghes, Paul Porensky | 2022-04-26 |
| 11219696 | Delivery of polynucleotides using recombinant AAV9 | Kevin Foust | 2022-01-11 |
| 11040116 | Intrathecal delivery of recombinant adeno-associated virus 9 | Arthur Burghes, Paul Porensky | 2021-06-22 |
| 10907130 | Methods and materials for producing recombinant viruses in eukaryotic microalgae | — | 2021-02-02 |
| 10842886 | Guided injections for AAV gene transfer to muscle | Jerry R. Mendell, Samiah Al-Zaidy | 2020-11-24 |
| 10793861 | Products and methods for treatment of familial amyotrophic lateral sclerosis | Kevin Foust, Don W. Cleveland | 2020-10-06 |
| 10357543 | Methods and compositions for treating disorders and diseases using Survival Motor Neuron (SMN) protein | Arthur Burghes, William D. Arnold, Vicki McGovern | 2019-07-23 |
| 10214566 | Mutant adeno-associated virus virions and methods of use thereof | David V. Schaffer, Narendra Maheshri | 2019-02-26 |
| 10046016 | Mutant adeno-associated virus virions and methods of use thereof | David V. Schaffer, Narendra Maheshri | 2018-08-14 |
| 9725716 | Non-ionic, low osmolar contrast agents for delivery of antisense oligonucleotides and treatment of disease | Arthur Burghes, Paul Porensky | 2017-08-08 |
| 9725719 | Compositions and methods for inhibiting NF-κB and SOD-1 to treat amyotrophic lateral sclerosis | Ashley E. Frakes | 2017-08-08 |
| 9539307 | Compositions and methods for treating amyotrophic lateral sclerosis | — | 2017-01-10 |
| 9441244 | Mutant adeno-associated virus virions and methods of use thereof | David V. Schaffer, Narendra Maheshri | 2016-09-13 |
| 9415121 | Delivery of MECP2 polynucleotide using recombinant AAV9 | Kevin Foust | 2016-08-16 |
| 9233131 | Mutant adeno-associated virus virions and methods of use thereof | David V. Schaffer, Narendra Maheshri | 2016-01-12 |